Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
In Vitro DiagnosticsCancer

PUBLISHER: Data Bridge Market Research | PRODUCT CODE: 1276884

Cover Image

PUBLISHER: Data Bridge Market Research | PRODUCT CODE: 1276884

MEA Liver Cancer Diagnostics Market - Industry Trends and Forecast to 2030

PUBLISHED:
PAGES: 269 Pages
DELIVERY TIME: Inquiry
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License) - Printable/Downloadable
USD 3500
PDF (Enterprise License) - Printable/Downloadable
USD 4200

Add to Cart

Description

Table of Contents

List of Tables

The Middle East and Africa liver cancer diagnostics market is projected to register a substantial CAGR of 4.2% in the forecast period of 2023 to 2030. The new market report contains data for the historic year 2021, the base year of calculation is 2022, and the forecast period is 2023 to 2030.

Market Segmentation:

Middle East and Africa Liver Cancer Diagnostics Market, By Test Type (Imaging, Biopsy, Genomic Test, and Others), Cancer Stages (Stage 0, Stage I, Stage II, Stage III, and Stage IV), Cancer Type (Primary Liver Cancer and Secondary Liver Cancer), Product (Platform-Based Products, Instrument Based Products, Kits and Reagents, and Other Consumables), Technology (Fluorescent In Situ Hybridization, Next Generation Sequencing, Fluorimmunoassay, Comparative Genomic Hybridization, Immunohistochemical, and Others), Application (Screening, Diagnostic and Predictive, Prognostic, and Research), Gender (Female and Male), End User (Hospitals, Diagnostic Centers, Cancer Research Centers, Academic Institutes, Ambulatory Surgical Centers, and Others), Distribution Channel (Direct Tender, Retail Sales, and Others), Country (South Africa, Saudi Arabia, Egypt, Israel and the Rest of Middle East and Africa) - Industry Trends and Forecast to 2030.

Some of the major factors contributing to the growth of Middle East and Africa liver cancer diagnostics market are:

Increasing cases of liver cancer

Growing demand for better quality healthcare

Market Players:

Some of the major players operating in the Middle East and Africa liver cancer diagnostics market are:

F. Hoffmann-La Roche Ltd.

Koninklijke Philips N.V.

Thermo Fisher Scientific Inc.

BD

Siemens Healthcare GmbH

Agilent Technologies, Inc.

Illumina, Inc.

QIAGEN

FUJIFILM Corporation

Sysmex Corporation AB

Scitex Pte Ltd. (Subsidiary of Danaher.)

Epigenomics AG

Tebubio

Fujirebio

Diagnostic Biosystems Inc.

Q-LINE BIOTECH PVT LTD.

MOLGEN

BIOCEPT, INC.

Boditech Med Inc.

Elabscience Biotechnology Inc.

Hipro Biotechnology Co., Ltd.

Altogen Biosystems

Tosoh India Pvt. Ltd.

ABK Biomedical Inc.

Diazyme Laboratories, Inc.

Show more

TABLE OF CONTENTS

1 INTRODUCTION 55

  • 1.1 OBJECTIVES OF THE STUDY 55
  • 1.2 MARKET DEFINITION 55
  • 1.3 OVERVIEW OF THE MIDDLE EAST & AFRICA LIVER CANCER DIAGNOSTICS MARKET 55
  • 1.4 CURRENCY AND PRICING 57
  • 1.5 LIMITATIONS 57
  • 1.6 MARKETS COVERED 58

2 MARKET SEGMENTATION 61

  • 2.1 MARKETS COVERED 61
  • 2.2 GEOGRAPHICAL SCOPE 62
  • 2.3 YEARS CONSIDERED FOR THE STUDY 63
  • 2.4 DBMR TRIPOD DATA VALIDATION MODEL 64
  • 2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 67
  • 2.6 MULTIVARIATE MODELLING 68
  • 2.7 MARKET APPLICATION COVERAGE GRID 69
  • 2.8 TEST TYPE LIFELINE CURVE 70
  • 2.9 DBMR MARKET POSITION GRID 71
  • 2.10 VENDOR SHARE ANALYSIS 72
  • 2.11 SECONDARY SOURCES 73
  • 2.12 ASSUMPTIONS 73

3 EXECUTIVE SUMMARY 74

4 PREMIUM INSIGHTS 77

  • 4.1 PESTLE ANALYSIS 78
  • 4.2 PORTER ANALYSIS 79
  • 4.3 EPIDEMIOLOGY 80

5 MIDDLE EAST & AFRICA LIVER CANCER DIAGNOSTICS MARKET, REGULATIONS 81

6 INDUSTRY INSIGHTS 85

7 MARKET OVERVIEW 87

  • 7.1 DRIVERS 89
    • 7.1.1 UNMET NEED FOR NON-INVASIVE, ACCURATE, AND RELIABLE DIAGNOSTIC TESTS FOR EARLIER CANCER DETECTION 89
    • 7.1.2 INCREASING EARLY DIAGNOSIS OF LIVER CANCER 90
    • 7.1.3 INCREASING CASES OF LIVER CANCER 92
    • 7.1.4 RISE IN DIAGNOSTIC PRODUCT APPROVALS 93
  • 7.2 RESTRAINTS 95
    • 7.2.1 BARRIERS TO LIVER CANCER DIAGNOSIS AND POOR PROGNOSIS 95
    • 7.2.2 HIGH FALSE-POSITIVES AND POOR SENSITIVITY OF LIVER CANCER DIAGNOSIS 96
  • 7.3 OPPORTUNITIES 96
    • 7.3.1 INCREASING AWARENESS TOWARDS LIVER CANCER 96
    • 7.3.2 GOVERNMENT INITIATIVES TOWARD LIVER CANCER DIAGNOSTICS 96
    • 7.3.3 GROWING DEMAND FOR BETTER QUALITY HEALTHCARE 97
  • 7.4 CHALLENGES 98
    • 7.4.1 STRICT REGULATIONS FOR THE APPROVAL OF LIVER CANCER DIAGNOSTIC PRODUCTS 98
    • 7.4.2 LACK OF SKILLED AND CERTIFIED EXPERTISE 99

8 MIDDLE EAST & AFRICA LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE 100

  • 8.1 OVERVIEW 101
  • 8.2 IMAGING TEST 104
    • 8.2.1 MAGNETIC RESONANCE IMAGING (MRI) 105
      • 8.2.1.1 MR ANGIOGRAPHY (MRA) 105
      • 8.2.1.2 MR CHOLANGIOPANCREATOGRAPHY 106
    • 8.2.2 COMPUTED TOMOGRAPHY 106
    • 8.2.3 POSITRON EMISSION TOMOGRAPHY 106
    • 8.2.4 ULTRASOUND 106
    • 8.2.5 OTHERS 106
  • 8.3 GENOMIC TEST 106
  • 8.4 BIOPSY 107
    • 8.4.1 FINE NEEDLE ASPIRATION BIOPSY 108
    • 8.4.2 CORE NEEDLE BIOPSY 108
    • 8.4.3 LAPAROSCOPY 108
  • 8.5 OTHERS 109

9 MIDDLE EAST & AFRICA LIVER CANCER DIAGNOSTICS MARKET, BY CANCER STAGE 110

  • 9.1 OVERVIEW 111
  • 9.2 STAGE III 114
  • 9.3 STAGE II 115
  • 9.4 STAGE IV 116
  • 9.5 STAGE I 117
  • 9.6 STAGE 0 118

10 MIDDLE EAST & AFRICA LIVER CANCER DIAGNOSTICS MARKET, BY CANCER TYPE 119

  • 10.1 OVERVIEW 120
  • 10.2 SECONDARY LIVER CANCER 123
    • 10.2.1 HEMANGIOMA 124
    • 10.2.2 HEPATIC ADENOMA 124
    • 10.2.3 FOCAL NODULAR HYPERPLASIA 124
  • 10.3 PRIMARY LIVER CANCER 124
    • 10.3.1 HEPATOCELLULAR CARCINOMA (HCC) 125
    • 10.3.2 INTRAHEPATIC CHOLANGIOCARCINOMA (BILE DUCT CANCER) 125
    • 10.3.3 ANGIOSARCOMA HEMANGIOSARCOMA 126
    • 10.3.4 HEPATOBLASTOMA 126

11 MIDDLE EAST & AFRICA LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT 127

  • 11.1 OVERVIEW 128
  • 11.2 PLATFORM BASED PRODUCTS 131
    • 11.2.1 NEXT GENERATION SEQUENCING 132
    • 11.2.2 MICROARRAYS 132
    • 11.2.3 PCR 132
    • 11.2.4 OTHERS 132
  • 11.3 INSTRUMENT BASED PRODUCTS 132
    • 11.3.1 IMAGING 133
    • 11.3.2 BIOPSY 133
  • 11.4 KITS AND REAGENTS 134
    • 11.4.1 ELISA TEST KITS 135
    • 11.4.2 CASSETTE TEST KITS 135
    • 11.4.3 OTHERS 135
  • 11.5 OTHER CONSUMABLES 135

12 MIDDLE EAST & AFRICA LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION 136

  • 12.1 OVERVIEW 137
  • 12.2 SCREENING 140
    • 12.2.1 PLATFORM BASED PRODUCTS 141
    • 12.2.2 INSTRUMENT BASED PRODUCTS 141
    • 12.2.3 KITS AND REAGENTS 141
    • 12.2.4 OTHER CONSUMABLES 141
  • 12.3 DIAGNOSTIC AND PREDICTIVE 141
    • 12.3.1 PLATFORM BASED PRODUCTS 142
    • 12.3.2 INSTRUMENT BASED PRODUCTS 142
    • 12.3.3 KITS AND REAGENTS 142
    • 12.3.4 OTHER CONSUMABLES 143
  • 12.4 PROGNOSTIC 143
    • 12.4.1 PLATFORM BASED PRODUCTS 144
    • 12.4.2 INSTRUMENT BASED PRODUCTS 144
    • 12.4.3 KITS AND REAGENTS 144
    • 12.4.4 OTHER CONSUMABLES 144
  • 12.5 RESEARCH 144
    • 12.5.1 PLATFORM BASED PRODUCTS 146
    • 12.5.2 INSTRUMENT BASED PRODUCTS 146
    • 12.5.3 KITS AND REAGENTS 146
    • 12.5.4 OTHER CONSUMABLES 146

13 MIDDLE EAST & AFRICA LIVER CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY 147

  • 13.1 OVERVIEW 148
  • 13.2 FLUORESCENT IN SITU HYBRIDIZATION 151
  • 13.3 NEXT GENERATION SEQUENCING 152
  • 13.4 FLUORIMMUNOASSAY 153
  • 13.5 COMPARATIVE GENOMIC HYBRIDIZATION 154
  • 13.6 IMMUNOHISTOCHEMICAL 155
  • 13.7 OTHERS 156

14 MIDDLE EAST & AFRICA LIVER CANCER DIAGNOSTICS MARKET, BY GENDER 157

  • 14.1 OVERVIEW 158
  • 14.2 MALE 161
  • 14.3 FEMALE 162

15 MIDDLE EAST & AFRICA LIVER CANCER DIAGNOSTICS MARKET, BY END USER 163

  • 15.1 OVERVIEW 164
  • 15.2 HOSPITALS 167
  • 15.3 DIAGNOSTIC CENTERS 168
  • 15.4 CANCER RESEARCH CENTERS 169
  • 15.5 AMBULATORY SURGICAL CENTERS 170
  • 15.6 ACADEMIC INSTITUTES 171
  • 15.7 OTHERS 172

16 MIDDLE EAST & AFRICA LIVER CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL 173

  • 16.1 OVERVIEW 174
  • 16.2 DIRECT TENDER 177
  • 16.3 RETAIL SALES 178
  • 16.4 OTHERS 179

17 MIDDLE EAST & AFRICA LIVER CANCER DIAGNOSTICS MARKET, BY REGION 180

  • 17.1 MIDDLE EAST AND AFRICA 181
    • 17.1.1 SOUTH AFRICA 192
    • 17.1.2 SAUDI ARABIA 198
    • 17.1.3 U.A.E. 204
    • 17.1.4 EGYPT 210
    • 17.1.5 ISRAEL 216
    • 17.1.6 REST OF MIDDLE EAST AND AFRICA 222

18 MIDDLE EAST & AFRICA LIVER CANCER DIAGNOSTICS MARKET, COMPANY LANDSCAPE 223

  • 18.1 COMPANY SHARE ANALYSIS: MIDDLE EAST & AFRICA 223

19 SWOT ANALYSIS 224

20 COMPANY PROFILE 225

  • 20.1 F. HOFFMANN-LA ROCHE LTD. 225
    • 20.1.1 COMPANY SNAPSHOT 225
    • 20.1.2 REVENUE ANALYSIS 225
    • 20.1.3 COMPANY SHARE ANALYSIS 226
    • 20.1.4 PRODUCT PORTFOLIO 226
    • 20.1.5 RECENT DEVELOPMENT 226
  • 20.2 KONINLIJKE PHILIPS N.V. 227
    • 20.2.1 COMPANY SNAPSHOT 227
    • 20.2.2 REVENUE ANALYSIS 227
    • 20.2.3 COMPANY SHARE ANALYSIS 228
    • 20.2.4 PRODUCT PORTFOLIO 228
    • 20.2.5 RECENT DEVELOPMENT 228
  • 20.3 THERMO FISHER SCIENTIFIC INC. 229
    • 20.3.1 COMPANY SNAPSHOT 229
    • 20.3.2 REVENUE ANALYSIS 229
    • 20.3.3 COMPANY SHARE ANALYSIS 230
    • 20.3.4 PRODUCT PORTFOLIO 230
    • 20.3.5 RECENT DEVELOPMENT 230
  • 20.4 BD 231
    • 20.4.1 COMPANY SNAPSHOT 231
    • 20.4.2 REVENUE ANALYSIS 231
    • 20.4.3 COMPANY SHARE ANALYSIS 232
    • 20.4.4 PRODUCT PORTFOLIO 232
    • 20.4.5 RECENT DEVELOPMENTS 233
  • 20.5 SIEMENS HEALTHCARE GMBH 234
    • 20.5.1 COMPANY SNAPSHOT 234
    • 20.5.2 REVENUE ANALYSIS 234
    • 20.5.3 COMPANY SHARE ANALYSIS 235
    • 20.5.4 PRODUCT PORTFOLIO 235
    • 20.5.5 RECENT DEVELOPMENT 235
  • 20.6 AGILENT TECHNOLOGIES, INC. 236
    • 20.6.1 COMPANY SNAPSHOT 236
    • 20.6.2 REVENUE ANALYSIS 236
    • 20.6.3 PRODUCT PORTFOLIO 237
    • 20.6.4 RECENT DEVELOPMENTS 237
  • 20.7 ABK BIOMEDICAL INC. 238
    • 20.7.1 COMPANY SNAPSHOT 238
    • 20.7.2 PRODUCT PORTFOLIO 238
    • 20.7.3 RECENT DEVELOPMENT 238
  • 20.8 AB SCIEX PTE LTD. (SUBSIDIARY OF DANAHER.) 239
    • 20.8.1 COMPANY SNAPSHOT 239
    • 20.8.2 REVENUE ANALYSIS 239
    • 20.8.3 PRODUCT PORTFOLIO 240
    • 20.8.4 RECENT DEVELOPMENT 240
  • 20.9 ALTOGEN BIOSYSTEMS 241
    • 20.9.1 COMPANY SNAPSHOT 241
    • 20.9.2 PRODUCT PORTFOLIO 241
    • 20.9.3 RECENT DEVELOPMENT 241
  • 20.10 BIOCEPT, INC. 242
    • 20.10.1 COMPANY SNAPSHOT 242
    • 20.10.2 REVENUE ANALYSIS 242
    • 20.10.3 PRODUCT PORTFOLIO 243
    • 20.10.4 RECENT DEVELOPMENT 243
  • 20.11 BODITECH MED INC. 244
    • 20.11.1 COMPANY SNAPSHOT 244
    • 20.11.2 PRODUCT PORTFOLIO 244
    • 20.11.3 RECENT DEVELOPMENTS 244
  • 20.12 DIAGNOSTIC BIOSYSTEMS INC. 245
    • 20.12.1 COMPANY SNAPSHOT 245
    • 20.12.2 PRODUCT PORTFOLIO 245
    • 20.12.3 RECENT DEVELOPMENT 245
  • 20.13 DIAZYME LABORATORIES, INC. 246
    • 20.13.1 COMPANY SNAPSHOT 246
    • 20.13.2 PRODUCT PORTFOLIO 246
    • 20.13.3 RECENT DEVELOPMENT 246
  • 20.14 ELABSCIENCE BIOTECHNOLOGY INC. 247
    • 20.14.1 COMPANY SNAPSHOT 247
    • 20.14.2 PRODUCT PORTFOLIO 247
    • 20.14.3 RECENT DEVELOPMENT 247
  • 20.15 EPIGENOMICS AG 248
    • 20.15.1 COMPANY SNAPSHOT 248
    • 20.15.2 REVENUE ANALYSIS 248
    • 20.15.3 PRODUCT PORTFOLIO 249
    • 20.15.4 RECENT DEVELOPMENT 249
  • 20.16 FUJIFILM CORPORATION 250
    • 20.16.1 COMPANY SNAPSHOT 250
    • 20.16.2 REVENUE ANALYSIS 250
    • 20.16.3 PRODUCT PORTFOLIO 251
    • 20.16.4 RECENT DEVELOPMENT 251
  • 20.17 FUJIREBIO 252
    • 20.17.1 COMPANY SNAPSHOT 252
    • 20.17.2 PRODUCT PORTFOLIO 252
    • 20.17.3 RECENT DEVELOPMENTS 252
  • 20.18 HIPRO BIOTECHNOLOGY CO., LTD. 253
    • 20.18.1 COMPANY SNAPSHOT 253
    • 20.18.2 PRODUCT PORTFOLIO 253
    • 20.18.3 RECENT DEVELOPMENT 253
  • 20.19 ILLUMINA, INC. 254
    • 20.19.1 COMPANY SNAPSHOT 254
    • 20.19.2 REVENUE ANALYSIS 254
    • 20.19.3 PRODUCT PORTFOLIO 255
    • 20.19.4 RECENT DEVELOPMENTS 256
  • 20.20 MOLGEN 257
    • 20.20.1 COMPANY SNAPSHOT 257
    • 20.20.2 PRODUCT PORTFOLIO 257
    • 20.20.3 RECENT DEVELOPMENT 257
  • 20.21 QIAGEN 258
    • 20.21.1 COMPANY SNAPSHOT 258
    • 20.21.2 REVENUE ANALYSIS 258
    • 20.21.3 PRODUCT PORTFOLIO 259
    • 20.21.4 RECENT DEVELOPMENT 259
Show more
  • 20.22 Q-LINE BIOTECH PVT LTD. 260
    • 20.22.1 COMPANY SNAPSHOT 260
    • 20.22.2 PRODUCT PORTFOLIO 260
    • 20.22.3 RECENT DEVELOPMENT 260
  • 20.23 SYSMEX CORPORATION 261
    • 20.23.1 COMPANY SNAPSHOT 261
    • 20.23.2 REVENUE ANALYSIS 261
    • 20.23.3 PRODUCT PORTFOLIO 262
    • 20.23.4 RECENT DEVELOPMENT 262
  • 20.24 TEBUBIO 263
    • 20.24.1 COMPANY SNAPSHOT 263
    • 20.24.2 PRODUCT PORTFOLIO 263
    • 20.24.3 RECENT DEVELOPMENT 263
  • 20.25 TOSOH INDIA PVT. LTD. 264
    • 20.25.1 COMPANY SNAPSHOT 264
    • 20.25.2 PRODUCT PORTFOLIO 264
    • 20.25.3 RECENT DEVELOPMENT 264

21 QUESTIONNAIRE 265

22 RELATED REPORTS 269

LIST OF TABLES

  • TABLE 1 DIFFERENT TYPES OF CANCER NON-INVASIVE SCREENING TESTS FOR DIFFERENT TYPES OF CANCERS 60
  • TABLE 2 LIVER CANCER RATES 63
  • TABLE 3 APPROVED DIAGNOSTICS OF LIVER CANCER 64
  • TABLE 4 MIDDLE EAST & AFRICA LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 73
  • TABLE 5 MIDDLE EAST & AFRICA IMAGING IN LIVER CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 74
  • TABLE 6 MIDDLE EAST & AFRICA IMAGING TEST IN LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 75
  • TABLE 7 MIDDLE EAST & AFRICA MAGNETIC RESONANCE IMAGING (MRI) IN LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 75
  • TABLE 8 MIDDLE EAST & AFRICA GENETIC TEST IN LIVER CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 77
  • TABLE 9 MIDDLE EAST & AFRICA BIOPSY IN LIVER CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 78
  • TABLE 10 MIDDLE EAST & AFRICA BIOPSY IN LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 78
  • TABLE 11 MIDDLE EAST & AFRICA OTHERS IN LIVER CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 79
  • TABLE 12 MIDDLE EAST & AFRICA LIVER CANCER DIAGNOSTICS MARKET, BY CANCER STAGE, 2021-2030 (USD MILLION) 83
  • TABLE 13 MIDDLE EAST & AFRICA STAGE III IN LIVER CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 84
  • TABLE 14 MIDDLE EAST & AFRICA STAGE II IN LIVER CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 85
  • TABLE 15 MIDDLE EAST & AFRICA STAGE IV IN LIVER CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 86
  • TABLE 16 MIDDLE EAST & AFRICA STAGE I IN LIVER CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 87
  • TABLE 17 MIDDLE EAST & AFRICA STAGE 0 IN LIVER CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 88
  • TABLE 18 MIDDLE EAST & AFRICA LIVER CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 92
  • TABLE 19 MIDDLE EAST & AFRICA SECONDARY LIVER CANCER IN LIVER CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 93
  • TABLE 20 MIDDLE EAST & AFRICA RENAL CELL CARCINOMA IN LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 94
  • TABLE 21 MIDDLE EAST & AFRICA CLEAR CELL RENAL CELL CARCINOMA IN LIVER CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 95
  • TABLE 22 MIDDLE EAST & AFRICA CLEAR CELL RENAL CELL CARCINOMA IN LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 95
  • TABLE 23 MIDDLE EAST & AFRICA LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 100
  • TABLE 24 MIDDLE EAST & AFRICA PLATFORM BASED PRODUCTS IN LIVER CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 101
  • TABLE 25 MIDDLE EAST & AFRICA PLATFORM BASED PRODUCTS IN LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 101
  • TABLE 26 MIDDLE EAST & AFRICA INSTRUMENT BASED PRODUCTS IN LIVER CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 103
  • TABLE 27 MIDDLE EAST & AFRICA INSTRUMENT BASED PRODUCTS IN LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 103
  • TABLE 28 MIDDLE EAST & AFRICA KITS AND REAGENTS IN LIVER CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 104
  • TABLE 29 MIDDLE EAST & AFRICA KITS AND REAGENTS IN LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 104
  • TABLE 30 MIDDLE EAST & AFRICA OTHER CONSUMABLES IN LIVER CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 105
  • TABLE 31 MIDDLE EAST & AFRICA LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 109
  • TABLE 32 MIDDLE EAST & AFRICA SCREENING IN LIVER CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 110
  • TABLE 33 MIDDLE EAST & AFRICA SCREENING IN LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 110
  • TABLE 34 MIDDLE EAST & AFRICA DIAGNOSTIC AND PREDICTIVE IN LIVER CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 112
  • TABLE 35 MIDDLE EAST & AFRICA DIAGNOSTIC AND PREDICTIVE IN LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 112
  • TABLE 36 MIDDLE EAST & AFRICA PROGNOSTIC IN LIVER CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 113
  • TABLE 37 MIDDLE EAST & AFRICA PROGNOSTIC IN LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 114
  • TABLE 38 MIDDLE EAST & AFRICA RESEARCH IN LIVER CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 115
  • TABLE 39 MIDDLE EAST & AFRICA RESEARCH IN LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 115
  • TABLE 40 MIDDLE EAST & AFRICA LIVER CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION) 120
  • TABLE 41 MIDDLE EAST & AFRICA FLUORESCENT IN SITU HYBRIDIZATION IN LIVER CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 121
  • TABLE 42 MIDDLE EAST & AFRICA NEXT GENERATION SEQUENCING IN LIVER CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 122
  • TABLE 43 MIDDLE EAST & AFRICA FLUORIMMUNOASSAY IN LIVER CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 123
  • TABLE 44 MIDDLE EAST & AFRICA COMPARATIVE GENOMIC HYBRIDIZATION IN LIVER CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 124
  • TABLE 45 MIDDLE EAST & AFRICA IMMUNOHISTOCHEMICAL IN LIVER CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 125
  • TABLE 46 MIDDLE EAST & AFRICA OTHERS IN LIVER CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 126
  • TABLE 47 MIDDLE EAST & AFRICA LIVER CANCER DIAGNOSTICS MARKET, BY GENDER, 2021-2030 (USD MILLION) 130
  • TABLE 48 MIDDLE EAST & AFRICA MALE IN LIVER CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 131
  • TABLE 49 MIDDLE EAST & AFRICA FEMALE IN LIVER CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 132
  • TABLE 50 MIDDLE EAST & AFRICA LIVER CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION) 136
  • TABLE 51 MIDDLE EAST & AFRICA HOSPITALS IN LIVER CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 137
  • TABLE 52 MIDDLE EAST & AFRICA DIAGNOSTIC CENTERS IN LIVER CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 138
  • TABLE 53 MIDDLE EAST & AFRICA CANCER RESEARCH CENTERS IN LIVER CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 139
  • TABLE 54 MIDDLE EAST & AFRICA AMBULATORY SURGICAL CENTERS IN LIVER CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 140
  • TABLE 55 MIDDLE EAST & AFRICA ACADEMIC INSTITUTES IN LIVER CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 141
  • TABLE 56 MIDDLE EAST & AFRICA OTHERS IN LIVER CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 142
  • TABLE 57 MIDDLE EAST & AFRICA LIVER CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 146
  • TABLE 58 MIDDLE EAST & AFRICA DIRECT TENDER IN LIVER CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 147
  • TABLE 59 MIDDLE EAST & AFRICA RETAIL SALES IN LIVER CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 148
  • TABLE 60 MIDDLE EAST & AFRICA OTHERS IN LIVER CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 149
  • TABLE 61 MIDDLE EAST AND AFRICA LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 156
  • TABLE 62 MIDDLE EAST AND AFRICA IMAGING TEST IN LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 156
  • TABLE 63 MIDDLE EAST AND AFRICA MAGNETIC RESONANCE IMAGING (MRI) IN LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE 2021-2030 (USD MILLION) 156
  • TABLE 64 MIDDLE EAST AND AFRICA BIOPSY IN LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 156
  • TABLE 65 MIDDLE EAST AND AFRICA LIVER CANCER DIAGNOSTICS MARKET, BY CANCER STAGES, 2021-2030 (USD MILLION) 157
  • TABLE 66 MIDDLE EAST AND AFRICA LIVER CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 157
  • TABLE 67 MIDDLE EAST AND AFRICA SECONDARY LIVER CANCER IN LIVER CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 157
  • TABLE 68 MIDDLE EAST AND AFRICA PRIMARY LIVER CANCER IN LIVER CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 157
  • TABLE 69 MIDDLE EAST AND AFRICA LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 158
  • TABLE 70 MIDDLE EAST AND AFRICA PLATFORM-BASED PRODUCTS IN LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 158
  • TABLE 71 MIDDLE EAST AND AFRICA INSTRUMENT-BASED PRODUCTS IN LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 158
  • TABLE 72 MIDDLE EAST AND AFRICA KITS & REAGENTS IN LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 158
  • TABLE 73 MIDDLE EAST AND AFRICA LIVER CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION) 159
  • TABLE 74 MIDDLE EAST AND AFRICA LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 159
  • TABLE 75 MIDDLE EAST AND AFRICA SCREENING IN LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 159
  • TABLE 76 MIDDLE EAST AND AFRICA DIAGNOSTIC AND PREDICTIVE IN LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 160
  • TABLE 77 MIDDLE EAST AND AFRICA PROGNOSTIC IN LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 160
  • TABLE 78 MIDDLE EAST AND AFRICA RESEARCH IN LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 160
  • TABLE 79 MIDDLE EAST AND AFRICA LIVER CANCER DIAGNOSTICS MARKET, BY GENDER, 2021-2030 (USD MILLION) 160
  • TABLE 80 MIDDLE EAST AND AFRICA LIVER CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION) 161
  • TABLE 81 MIDDLE EAST AND AFRICA LIVER CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 161
  • TABLE 82 SOUTH AFRICA LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 162
  • TABLE 83 SOUTH AFRICA IMAGING TEST IN LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 162
  • TABLE 84 SOUTH AFRICA MAGNETIC RESONANCE IMAGING (MRI) IN LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE 2021-2030 (USD MILLION) 162
  • TABLE 85 SOUTH AFRICA BIOPSY IN LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 163
  • TABLE 86 SOUTH AFRICA LIVER CANCER DIAGNOSTICS MARKET, BY CANCER STAGES, 2021-2030 (USD MILLION) 163
  • TABLE 87 SOUTH AFRICA LIVER CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 163
  • TABLE 88 SOUTH AFRICA SECONDARY LIVER CANCER IN LIVER CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 163
  • TABLE 89 SOUTH AFRICA PRIMARY LIVER CANCER IN LIVER CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 164
  • TABLE 90 SOUTH AFRICA LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 164
  • TABLE 91 SOUTH AFRICA PLATFORM-BASED PRODUCTS IN LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 164
  • TABLE 92 SOUTH AFRICA INSTRUMENT-BASED PRODUCTS IN LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 165
  • TABLE 93 SOUTH AFRICA KITS & REAGENTS IN LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 165
  • TABLE 94 SOUTH AFRICA LIVER CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION) 165
  • TABLE 95 SOUTH AFRICA LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 165
  • TABLE 96 SOUTH AFRICA SCREENING IN LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 166
  • TABLE 97 SOUTH AFRICA DIAGNOSTIC AND PREDICTIVE IN LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 166
  • TABLE 98 SOUTH AFRICA PROGNOSTIC IN LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 166
  • TABLE 99 SOUTH AFRICA RESEARCH IN LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 166
  • TABLE 100 SOUTH AFRICA LIVER CANCER DIAGNOSTICS MARKET, BY GENDER, 2021-2030 (USD MILLION) 167
  • TABLE 101 SOUTH AFRICA LIVER CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION) 167
  • TABLE 102 SOUTH AFRICA LIVER CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 167
  • TABLE 103 SAUDI ARABIA LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 168
  • TABLE 104 SAUDI ARABIA IMAGING TEST IN LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 168
  • TABLE 105 SAUDI ARABIA MAGNETIC RESONANCE IMAGING (MRI) IN LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE 2021-2030 (USD MILLION) 168
  • TABLE 106 SAUDI ARABIA BIOPSY IN LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 169
  • TABLE 107 SAUDI ARABIA LIVER CANCER DIAGNOSTICS MARKET, BY CANCER STAGES, 2021-2030 (USD MILLION) 169
  • TABLE 108 SAUDI ARABIA LIVER CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 169
  • TABLE 109 SAUDI ARABIA SECONDARY LIVER CANCER IN LIVER CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 169
  • TABLE 110 SAUDI ARABIA PRIMARY LIVER CANCER IN LIVER CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 170
  • TABLE 111 SAUDI ARABIA LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 170
  • TABLE 112 SAUDI ARABIA PLATFORM-BASED PRODUCTS IN LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 170
  • TABLE 113 SAUDI ARABIA INSTRUMENT-BASED PRODUCTS IN LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 170
  • TABLE 114 SAUDI ARABIA KITS & REAGENTS IN LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 171
  • TABLE 115 SAUDI ARABIA LIVER CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION) 171
  • TABLE 116 SAUDI ARABIA LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 171
  • TABLE 117 SAUDI ARABIA SCREENING IN LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 172
  • TABLE 118 SAUDI ARABIA DIAGNOSTIC AND PREDICTIVE IN LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 172
  • TABLE 119 SAUDI ARABIA PROGNOSTIC IN LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 172
  • TABLE 120 SAUDI ARABIA RESEARCH IN LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 172
  • TABLE 121 SAUDI ARABIA LIVER CANCER DIAGNOSTICS MARKET, BY GENDER, 2021-2030 (USD MILLION) 173
  • TABLE 122 SAUDI ARABIA LIVER CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION) 173
  • TABLE 123 SAUDI ARABIA LIVER CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 173
  • TABLE 124 U.A.E LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 174
  • TABLE 125 U.A.E IMAGING TEST IN LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 174
  • TABLE 126 U.A.E MAGNETIC RESONANCE IMAGING (MRI) IN LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE 2021-2030 (USD MILLION) 174
  • TABLE 127 U.A.E BIOPSY IN LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 175
  • TABLE 128 U.A.E LIVER CANCER DIAGNOSTICS MARKET, BY CANCER STAGES, 2021-2030 (USD MILLION) 175
  • TABLE 129 U.A.E LIVER CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 175
  • TABLE 130 U.A.E SECONDARY LIVER CANCER IN LIVER CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 175
  • TABLE 131 U.A.E PRIMARY LIVER CANCER IN LIVER CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 176
  • TABLE 132 U.A.E LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 176
  • TABLE 133 U.A.E PLATFORM-BASED PRODUCTS IN LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 176
  • TABLE 134 U.A.E INSTRUMENT-BASED PRODUCTS IN LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 176
  • TABLE 135 U.A.E KITS & REAGENTS IN LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 177
  • TABLE 136 U.A.E LIVER CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION) 177
  • TABLE 137 U.A.E LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 177
  • TABLE 138 U.A.E SCREENING IN LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 177
  • TABLE 139 U.A.E DIAGNOSTIC AND PREDICTIVE IN LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 178
  • TABLE 140 U.A.E PROGNOSTIC IN LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 178
  • TABLE 141 U.A.E RESEARCH IN LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 178
  • TABLE 142 U.A.E LIVER CANCER DIAGNOSTICS MARKET, BY GENDER, 2021-2030 (USD MILLION) 178
  • TABLE 143 U.A.E LIVER CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION) 179
  • TABLE 144 U.A.E LIVER CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 179
  • TABLE 145 EGYPT LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 180
  • TABLE 146 EGYPT IMAGING TEST IN LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 180
  • TABLE 147 EGYPT MAGNETIC RESONANCE IMAGING (MRI) IN LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE 2021-2030 (USD MILLION) 180
  • TABLE 148 EGYPT BIOPSY IN LIVER CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 181
  • TABLE 149 EGYPT LIVER CANCER DIAGNOSTICS MARKET, BY CANCER STAGES, 2021-2030 (USD MILLION) 181
  • TABLE 150 EGYPT LIVER CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 181
  • TABLE 151 EGYPT SECONDARY LIVER CANCER IN LIVER CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 181
  • TABLE 152 EGYPT PRIMARY LIVER CANCER IN LIVER CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 182
  • TABLE 153 EGYPT LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 182
  • TABLE 154 EGYPT PLATFORM-BASED PRODUCTS IN LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 182
  • TABLE 155 EGYPT INSTRUMENT-BASED PRODUCTS IN LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 182
  • TABLE 156 EGYPT KITS & REAGENTS IN LIVER CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 183
  • TABLE 157 EGYPT LIVER CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION) 183
  • TABLE 158 EGYPT LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 183
  • TABLE 159 EGYPT SCREENING IN LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 183
  • TABLE 160 EGYPT DIAGNOSTIC AND PREDICTIVE IN LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 184
  • TABLE 161 EGYPT PROGNOSTIC IN LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 184
  • TABLE 162 EGYPT RESEARCH IN LIVER CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 184
  • TABLE 163 EGYPT LIVER CANCER DIAGNOSTICS MARKET, BY GENDER, 2021-2030 (USD MILLION) 184
  • TABLE 164 EGYPT LIVER CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION) 185

LIST OF FIGURES

  • FIGURE 1 MIDDLE EAST & AFRICA LIVER CANCER DIAGNOSTICS MARKET: SEGMENTATION 30
  • FIGURE 2 MIDDLE EAST & AFRICA LIVER CANCER DIAGNOSTICS MARKET: DATA TRIANGULATION 33
  • FIGURE 3 MIDDLE EAST & AFRICA LIVER CANCER DIAGNOSTICS MARKET: DROC ANALYSIS 34
  • FIGURE 4 MIDDLE EAST & AFRICA LIVER CANCER DIAGNOSTICS MARKET: MIDDLE EAST & AFRICA VS REGIONAL MARKET ANALYSIS 35
  • FIGURE 5 MIDDLE EAST & AFRICA LIVER CANCER DIAGNOSTICS MARKET: COMPANY RESEARCH ANALYSIS 35
  • FIGURE 6 MIDDLE EAST & AFRICA LIVER CANCER DIAGNOSTICS MARKET: INTERVIEW DEMOGRAPHICS 36
  • FIGURE 7 MIDDLE EAST & AFRICA LIVER CANCER DIAGNOSTICS MARKET: MARKET APPLICATION COVERAGE GRID 38
  • FIGURE 8 MIDDLE EAST & AFRICA LIVER CANCER DIAGNOSTICS MARKET: DBMR MARKET POSITION GRID 40
  • FIGURE 9 MIDDLE EAST & AFRICA LIVER CANCER DIAGNOSTICS MARKET: VENDOR SHARE ANALYSIS 41
  • FIGURE 10 MIDDLE EAST & AFRICA LIVER CANCER DIAGNOSTICS MARKET: SEGMENTATION 45
  • FIGURE 11 GROWING AWARENESS OF LIVER CANCER AND INCREASING HEALTHCARE EXPENDITURE ARE EXPECTED TO DRIVE THE GROWTH OF THE MIDDLE EAST & AFRICA LIVER CANCER DIAGNOSTICS MARKET FROM 2023 TO 2030 46
  • FIGURE 12 THE IMAGING TEST SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE MIDDLE EAST & AFRICA LIVER CANCER DIAGNOSTICS MARKET IN 2023 & 2030 46
  • FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE MIDDLE EAST & AFRICA LIVER CANCER DIAGNOSTICS MARKET 57
  • FIGURE 14 THE MIDDLE EAST & AFRICA MORTALITY RATE DUE TO CANCER 60
  • FIGURE 15 INCREASING MIDDLE EAST & AFRICA CANCER RATE IN 2020 61
  • FIGURE 16 BARRIERS TO EARLY CANCER DIAGNOSIS AND TREATMENT 64
  • FIGURE 17 MIDDLE EAST & AFRICA LIVER CANCER DIAGNOSTICS MARKET: BY TEST TYPE, 2022 70
  • FIGURE 18 MIDDLE EAST & AFRICA LIVER CANCER DIAGNOSTICS MARKET: BY TEST TYPE, 2023-2030 (USD MILLION) 71
  • FIGURE 19 MIDDLE EAST & AFRICA LIVER CANCER DIAGNOSTICS MARKET: BY TEST TYPE, CAGR (2023-2030) 71
  • FIGURE 20 MIDDLE EAST & AFRICA LIVER CANCER DIAGNOSTICS MARKET: BY TEST TYPE, LIFELINE CURVE 72
  • FIGURE 21 MIDDLE EAST & AFRICA LIVER CANCER DIAGNOSTICS MARKET: BY CANCER STAGE, 2022 80
  • FIGURE 22 MIDDLE EAST & AFRICA LIVER CANCER DIAGNOSTICS MARKET: BY CANCER STAGE, 2023-2030 (USD MILLION) 81
  • FIGURE 23 MIDDLE EAST & AFRICA LIVER CANCER DIAGNOSTICS MARKET: BY CANCER STAGE, CAGR (2023-2030) 81
  • FIGURE 24 MIDDLE EAST & AFRICA LIVER CANCER DIAGNOSTICS MARKET: BY CANCER STAGE, LIFELINE CURVE 82
  • FIGURE 25 MIDDLE EAST & AFRICA LIVER CANCER DIAGNOSTICS MARKET: BY CANCER TYPE, 2022 89
  • FIGURE 26 MIDDLE EAST & AFRICA LIVER CANCER DIAGNOSTICS MARKET: BY CANCER TYPE, 2023-2030 (USD MILLION) 90
  • FIGURE 27 MIDDLE EAST & AFRICA LIVER CANCER DIAGNOSTICS MARKET: BY CANCER TYPE, CAGR (2023-2030) 90
  • FIGURE 28 MIDDLE EAST & AFRICA LIVER CANCER DIAGNOSTICS MARKET: BY CANCER TYPE, LIFELINE CURVE 91
  • FIGURE 29 MIDDLE EAST & AFRICA LIVER CANCER DIAGNOSTICS MARKET: BY PRODUCT, 2022 97
  • FIGURE 30 MIDDLE EAST & AFRICA LIVER CANCER DIAGNOSTICS MARKET: BY PRODUCT, 2023-2030 (USD MILLION) 98
  • FIGURE 31 MIDDLE EAST & AFRICA LIVER CANCER DIAGNOSTICS MARKET: BY PRODUCT, CAGR (2023-2030) 98
  • FIGURE 32 MIDDLE EAST & AFRICA LIVER CANCER DIAGNOSTICS MARKET: BY PRODUCT, LIFELINE CURVE 99
  • FIGURE 33 MIDDLE EAST & AFRICA LIVER CANCER DIAGNOSTICS MARKET: BY APPLICATION, 2022 106
  • FIGURE 34 MIDDLE EAST & AFRICA LIVER CANCER DIAGNOSTICS MARKET: BY APPLICATION, 2023-2030 (USD MILLION) 107
  • FIGURE 35 MIDDLE EAST & AFRICA LIVER CANCER DIAGNOSTICS MARKET: BY APPLICATION, CAGR (2023-2030) 107
  • FIGURE 36 MIDDLE EAST & AFRICA LIVER CANCER DIAGNOSTICS MARKET: BY APPLICATION, LIFELINE CURVE 108
  • FIGURE 37 MIDDLE EAST & AFRICA LIVER CANCER DIAGNOSTICS MARKET: BY TECHNOLOGY, 2022 117
  • FIGURE 38 MIDDLE EAST & AFRICA LIVER CANCER DIAGNOSTICS MARKET: BY TECHNOLOGY, 2023-2030 (USD MILLION) 118
  • FIGURE 39 MIDDLE EAST & AFRICA LIVER CANCER DIAGNOSTICS MARKET: BY TECHNOLOGY, CAGR (2023-2030) 118
  • FIGURE 40 MIDDLE EAST & AFRICA LIVER CANCER DIAGNOSTICS MARKET: BY TECHNOLOGY, LIFELINE CURVE 119
  • FIGURE 41 MIDDLE EAST & AFRICA LIVER CANCER DIAGNOSTICS MARKET: BY GENDER, 2022 127
  • FIGURE 42 MIDDLE EAST & AFRICA LIVER CANCER DIAGNOSTICS MARKET: BY GENDER, 2023-2030 (USD MILLION) 128
  • FIGURE 43 MIDDLE EAST & AFRICA LIVER CANCER DIAGNOSTICS MARKET: BY GENDER, CAGR (2023-2030) 128
  • FIGURE 44 MIDDLE EAST & AFRICA LIVER CANCER DIAGNOSTICS MARKET: BY GENDER, LIFELINE CURVE 129
  • FIGURE 45 MIDDLE EAST & AFRICA LIVER CANCER DIAGNOSTICS MARKET: BY END USER, 2022 133
  • FIGURE 46 MIDDLE EAST & AFRICA LIVER CANCER DIAGNOSTICS MARKET: BY END USER, 2023-2030 (USD MILLION) 134
  • FIGURE 47 MIDDLE EAST & AFRICA LIVER CANCER DIAGNOSTICS MARKET: BY END USER, CAGR (2023-2030) 134
  • FIGURE 48 MIDDLE EAST & AFRICA LIVER CANCER DIAGNOSTICS MARKET: BY END USER, LIFELINE CURVE 135
  • FIGURE 49 MIDDLE EAST & AFRICA LIVER CANCER DIAGNOSTICS MARKET: BY DISTRIBUTION CHANNEL, 2022 143
  • FIGURE 50 MIDDLE EAST & AFRICA LIVER CANCER DIAGNOSTICS MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION) 144
  • FIGURE 51 MIDDLE EAST & AFRICA LIVER CANCER DIAGNOSTICS MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030) 144
  • FIGURE 52 MIDDLE EAST & AFRICA LIVER CANCER DIAGNOSTICS MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE 145
  • FIGURE 53 MIDDLE EAST AND AFRICA LIVER CANCER DIAGNOSTICS MARKET: SNAPSHOT (2022) 151
  • FIGURE 54 MIDDLE EAST AND AFRICA LIVER CANCER DIAGNOSTICS MARKET: BY COUNTRY (2022) 153
  • FIGURE 55 MIDDLE EAST AND AFRICA LIVER CANCER DIAGNOSTICS MARKET: BY COUNTRY (2023 & 2030) 153
  • FIGURE 56 MIDDLE EAST AND AFRICA LIVER CANCER DIAGNOSTICS MARKET: BY COUNTRY (2022 & 2030) 154
  • FIGURE 57 MIDDLE EAST AND AFRICA LIVER CANCER DIAGNOSTICS MARKET: TEST TYPE (2023-2030) 154
  • FIGURE 58 MIDDLE EAST & AFRICA LIVER CANCER DIAGNOSTICS MARKET: COMPANY SHARE 2022 (%) 192
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!